Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)

被引：0
|
作者：
Guanggai Xia
Hongcheng Wang
Ziliang Song
Qingcai Meng
Xiuyan Huang
Xinyu Huang
机构：
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of general surgery
[2] Fudan University Shanghai Cancer Center,Department of Pancreatic Surgery, Pancreatic Cancer Institute
来源：
Journal of Experimental & Clinical Cancer Research | / 36卷
关键词：
Pancreatic cancer; Gemcitabine; Gambogic acid; RRM2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 33 条
  • [1] Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)
    Xia, Guanggai
    Wang, Hongcheng
    Song, Ziliang
    Meng, Qingcai
    Huang, Xiuyan
    Huang, Xinyu
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36 : 107
  • [2] Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors
    Kolesar, Jill
    Huang, Wei
    Eickhoff, Jens
    Hahn, Kristine
    Alberti, Dona
    Attia, Steven
    Schelman, William
    Holen, Kyle
    Traynor, Anne
    Ivy, Percy
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 79 - 86
  • [3] E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2
    Liu, Qianfan
    Song, Chunzhuo
    Li, Junjun
    Liu, Meng
    Fu, Liyue
    Jiang, Jiuliang
    Zeng, Zhirui
    Zhu, Haitao
    MEDICAL ONCOLOGY, 2022, 39 (09)
  • [4] E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2
    Qianfan Liu
    Chunzhuo Song
    Junjun Li
    Meng Liu
    Liyue FU
    Jiuliang Jiang
    Zhirui Zeng
    Haitao Zhu
    Medical Oncology, 39
  • [5] Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1
    Mitsuno, Mayumi
    Kitajima, Yoshihiko
    Ohtaka, Kazuma
    Kai, Keita
    Hashiguchi, Kazuyoshi
    Nakamura, Jun
    Hiraki, Masatsugu
    Noshiro, Hirokazu
    Miyazaki, Kohji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (02) : 341 - 349
  • [6] Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
    Nakahira, Shin
    Nakamori, Shoji
    Tsujie, Masanori
    Takahashi, Yuji
    Okami, Jiro
    Yoshioka, Shinichi
    Yamasaki, Makoto
    Marubashi, Shigeru
    Takemasa, Ichiro
    Miyamoto, Atsushi
    Takeda, Yutaka
    Nagano, Hiroaki
    Dono, Keizo
    Umeshita, Koji
    Sakon, Masato
    Monden, Morito
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (06) : 1355 - 1363
  • [7] DHS (trans-4,4′-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2)
    Chen, Chi-Wei
    Li, Yongming
    Hu, Shuya
    Zhou, Wei
    Meng, Yunxiao
    Li, Zongzhu
    Zhang, Yi
    Sun, Jing
    Bob, Zhou
    DePamphilis, Melvin L.
    Yen, Yun
    Han, Zhiyong
    Zhu, Wenge
    ONCOGENE, 2019, 38 (13) : 2364 - 2379
  • [8] Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2
    Tu, Min
    Li, Haifeng
    Lv, Nan
    Xi, Chunhua
    Lu, Zipeng
    Wei, Jishu
    Chen, Jianmin
    Guo, Feng
    Jiang, Kuirong
    Song, Guoxin
    Gao, Wentao
    Miao, Yi
    MOLECULAR CANCER, 2017, 16
  • [9] Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2
    Min Tu
    Haifeng Li
    Nan Lv
    Chunhua Xi
    Zipeng Lu
    Jishu Wei
    Jianmin Chen
    Feng Guo
    Kuirong Jiang
    Guoxin Song
    Wentao Gao
    Yi Miao
    Molecular Cancer, 16
  • [10] RETRACTED ARTICLE: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine
    Mark S Duxbury
    Hiromichi Ito
    Michael J Zinner
    Stanley W Ashley
    Edward E Whang
    Oncogene, 2004, 23 : 1539 - 1548
1234